The first clinical experiences with ethambutol in chronic pulmonary tuberculosis and basilar meningitis.
D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D002207:Capreomycin / Q000627:therapeutic use; D002908:Chronic Disease; D003523:Cycloserine / Q000627:therapeutic use; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000627:therapeutic use*; D005000:Ethionamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008581:Meningitis / Q000188:drug therapy*; D008875:Middle Aged; D011718:Pyrazinamide / Q000627:therapeutic use; D011859:Radiography; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery; D014756:Viomycin / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D004338:Drug Combinations; D002207:Capreomycin; D011718:Pyrazinamide; D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin